FDA data Registry peer set 1 peer

Alternatives to lemborexant

1 same-class SPL records vs lemborexant - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Dayvigo

Orexin Receptor Antagonist Prescription 1 alternative found

About lemborexant

Dayvigo is a medicine that can help you fall asleep and stay asleep. It is for adults who have trouble with insomnia.

Used for: Dayvigo is used to treat insomnia in adults. Insomnia means you have trouble falling asleep, staying asleep, or both. This medicine can help you sleep better.

1 Orexin Receptor Antagonist peers (wide set)

Compare lemborexant vs suvorexant side-by-side →

lemborexant vs suvorexant · FAERS reaction fields

FAERS top-reaction field "Somnolence" shows the widest count spread between lemborexant and suvorexant in this extract (598-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect lemborexant suvorexant
Suicide Attempt 133 -
Somnolence 128 726
Condition Aggravated 117 -
Suicidal Ideation 115 -
Fall 94 258
Headache 84 535
Sleep Paralysis 82 231
Nausea 80 381

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

lemborexant peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Orexin Receptor Antagonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside lemborexant?
This registry lists 1 Orexin Receptor Antagonist medication records beside lemborexant, including suvorexant. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Orexin Receptor Antagonist peer set (1 records)

lemborexant (Dayvigo) sits in a wide Orexin Receptor Antagonist peer set (1 of 1 class peers shown). Labeled indication field for lemborexant: Dayvigo is used to treat insomnia in adults.

Top FAERS reaction fields for lemborexant total 984 reports across 10 reactions, set beside suvorexant. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full lemborexant profile →

Field note for lemborexant: see also the generic vs brand label guide when reading Dayvigo SPL strings.